Commercial Partners - Intelligent Health Intelligent Health AI 2024 | Position your company in front of the brightest AI Healthcare brains

LET’S DO THINGS DIFFERENTLY. TOGETHER.

 

 

Position your company in front of the brightest AI Healthcare brains

Raise your company’s profile and get in front of the brightest healthcare AI brains, spanning the whole global ecosystem of pharmaceutical, biotech, medtech, clinicians and healthcare providers, health tech companies, insurers, academics and investors.

Sponsoring or exhibiting at Intelligent Health is an investment into your company’s future success. Whether your goals are to increase your market share, launch a new product, increase brand awareness, penetrate a new market sector or increase your sales, this event will provide you with the ultimate tool to achieve these goals.

Sponsoring an element of Intelligent Health ensures your company is promoted in the digital health marketplace. Join us and showcase your company’s brand and competitive edge to decision makers within the entire digital health ecosystem.

We’re open to new ideas and the team will work with you to create a package that directly meets your business needs, because in these uncertain times we know that every $$ counts.

A glimpse at the first 2024 Commercial Partners...

Contact us

Gold Partners

Contact us

Intelligent Health

Helbling Technik

The internationally operating Helbling Group, founded in 1963, positions itself as an interdisciplinary nexus of engineering and consulting expertise. At Helbling Technik, a daughter company of the Helbling Group, we have a powerful team of over 450 engineering, IT and physics specialists that create innovative ideas, technologies and products. Especially, we support startups, medium-sized companies and large corporations with recognizing and exploiting the potential of scientific informatics for digital health products.

Helbling Technik

Silver Partners

Contact us

Intelligent Health

Check4Cancer

Check4Cancer (C4C) is an award-winning early cancer detection company that provides tech-enabled solutions for cancer risk assessment, prevention, screening & diagnostics to insured, corporate & self-pay markets in UK. In 2021, C4C launched an online cancer risk questionnaire (MyCancerRisk) that underpins a risk-stratified cancer screening programme for insured or corporate clients. Since 2022, Check4Cancer has worked with the University of Essex to build an AI model for skin lesion classification using C4C’s large database of images and clinical metadata. A skin cancer app to allow high quality skin images to be taken at home will be launched in Q4 2024.

Check4Cancer
Intelligent Health

OM1

OM1 is an insights-driven technology and data company specializing in Personalized Medicine, Evidence Generation, and RWE Research powered by next-Gen A.I. platforms, regulatory-grade deep longitudinal data, and globally recognized thought leadership. Our unprecedented innovation takes RWE from Bench-to-Practice, delivering unparalleled personalized impact on the outcomes of patients and the advancement of research. We do things differently. We are pushing the boundaries of healthcare, reimagining how industry, providers, payers, and patients use real-world evidence. We are globally recognized for the integration of cutting-edge AI and data technologies. As pioneers in the field, our commitment to leveraging technology propels healthcare transformation, enhancing patient outcomes and setting new industry benchmarks.

OM1

Event Partners

Contact us

Intelligent Health

Intelligencia AI

Intelligencia AI™ leads the way in leveraging proprietary data, biomedical expertise and artificial intelligence (AI) with its patented technology to address significant challenges in the pharmaceutical industry. These challenges include lengthy drug development timelines, excessive costs, and unsustainable return on investment (ROI). Its suite of AI-powered solutions delivers actionable insights crucial in mitigating risks and enhancing decision-making associated with drug development by providing an accurate, unbiased assessment of a drug’s probability of success. Founded in 2017, Intelligencia AI is headquartered in New York, NY, with offices in San Francisco, CA, and Athens, Greece, and employs 110 individuals globally. Visit intelligencia.ai to discover more.

Intelligencia AI

Accelerator Partners

Contact us

Intelligent Health

WeWALK

What is the WeWALK Smart Cane?
There are approximately 253 million visually impaired people worldwide, and many rely on the white cane, a
simple tool primarily designed to provide ground-level obstacle detection. By equipping the white cane with
modern technology, WeWALK delivers a safer and more independent mobility experience to visually impaired people. WeWALK is more than a product;it is the first step in a societal transformation that fosters social inclusion by empowering visually impaired people.

The WeWALK Smart Cane can detect above ground obstacles by using a front-mounted sensor, warning the user with haptic feedback. The smart handle pairs with the accessible WeWALK smartphone app using Bluetooth to access connected mobility services, including navigation, exploration, and public transport. These features can be controlled from the smart cane’s inbuilt touchpad, allowing the user to place their phone in their pocket for single-handed navigation and added safety. In addition, the smart handle has a speaker and microphone to provide audio feedback. New smart city integrations and services are constantly being added via software updates, making WeWALK an ideal personal hub for the visually impaired community.

WeWALK

IH COMMERCIAL PARTNERS WALL OF FAME

Want to see your name here? Let’s talk.

Contact us

Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health

“The Intelligent Health summit was energizing, uplifting and educational! It was the best of AI without the hype – truly about how AI can impact and improve the health of all people, across diverse geographies, diseases and resources. It was exciting to see how many clinicians participated.”

Dr. Mimi Huizinga, Vice President, Strategic Data and Digital, US Oncology, Novartis Foundation

“Intelligent Health 2018 has proven to be the right platform for us to address our Health target audience in terms of level and function. The content shared by an impressive speaker line-up had great quality.”

Anne O’Riordan, Senior Managing Director Life Sciences, Accenture

“It was excellent to partner with Intelligent Health 2018 to ensure a strong focus on leveraging AI for child & adolescent health... and to coordinate our efforts so that AI serves all of humanity”

Stefan Germann, CEO, Fondation Botnar

DON’T MISS A THING!

Subscribe to the IH mailing list to be the first to receive the latest news, articles and reports, speakers announcements, programme updates, ticket sales and much more…

SUBSCRIBE TO NEWSLETTER